Atlas Trials

Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast Cancer

Clinical trial NCT04669132 · COMPLETED

Trial details

NCT number
NCT04669132
Sponsor
Instituto Brasileiro de Controle do Cancer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nausea Post Chemotherapy
Start date
2020-12-17
Primary completion
2021-12-17
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.